Hyman Phelps and McNamara
 
Firm Publications
 

The Cost of Inadequate Substantiation
November 5, 2010

Although FDA appears reluctant to take an aggressive stance with respect to substantiation of health-related claims for foods, FTC has forged ahead with a number of investigations of allegedly false or misleading advertising that have resulted in restrictive settlements - and the plaintiffs' bar has taken notice.


Click here to view the full Food Chemical News article

If you have any questions regarding the above information, please contact:
Paul M. Hyman (202) 737-4281 phyman@hpm.com
Ricardo Carvajal (202) 737-4586 rcarvajal@hpm.com